This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Interventional, open-label, flexible-dose extensio...
Clinical trial

Interventional, open-label, flexible-dose extension study of aripiprazole once-monthly in patients with schizophrenia

Read time: 1 mins
Last updated:24th Jul 2013
Long-term safety and tolerability of aripiprazole once-monthly (400 or 300 mg/month) in patients with schizophrenia who completed Study 14724A.
Category Value
Study start date 2013-07-24

View full details